226 related articles for article (PubMed ID: 34123681)
1. Postoperative Euglycemic Ketoacidosis in Type 2 Diabetes Associated with Sodium-Glucose Cotransporter 2 Inhibitor: Insights Into Pathogenesis and Management Strategy.
Chandrakumar HP; Chillumuntala S; Singh G; McFarlane SI
Cureus; 2021 Jun; 13(6):e15533. PubMed ID: 34123681
[TBL] [Abstract][Full Text] [Related]
2. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
[TBL] [Abstract][Full Text] [Related]
3. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis.
Patel K; Nair A
Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965
[TBL] [Abstract][Full Text] [Related]
4. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
Diaz-Ramos A; Eilbert W; Marquez D
Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
[TBL] [Abstract][Full Text] [Related]
5. Self-Induced Euglycemic Diabetic Ketoacidosis: When to Stop the Drip.
Zughaib MT; Patel K; Leka M; Affas S
Cureus; 2022 Jan; 14(1):e21768. PubMed ID: 35251838
[TBL] [Abstract][Full Text] [Related]
6. Euglycemic diabetic ketoacidosis: A missed diagnosis.
Nasa P; Chaudhary S; Shrivastava PK; Singh A
World J Diabetes; 2021 May; 12(5):514-523. PubMed ID: 33995841
[TBL] [Abstract][Full Text] [Related]
7. Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports.
Khedr A; Hennawi HA; Khan MK; Eissa A; Mir M; Rauf I; Nitesh J; Surani S; Khan SA
World J Clin Cases; 2023 Aug; 11(24):5700-5709. PubMed ID: 37727728
[TBL] [Abstract][Full Text] [Related]
8. Life-Threatening Complications Related to Delayed Diagnosis of Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Report of 2 Cases.
Goto S; Ishikawa JY; Idei M; Iwabuchi M; Namekawa M; Nomura T
Am J Case Rep; 2021 Mar; 22():e929773. PubMed ID: 33723205
[TBL] [Abstract][Full Text] [Related]
9. Euglycemic Diabetic Ketoacidosis Caused by Alcoholic Pancreatitis and Starvation Ketosis.
Han HJ; Cole AE; Verma A
J Gen Intern Med; 2023 Apr; 38(5):1299-1301. PubMed ID: 36689144
[TBL] [Abstract][Full Text] [Related]
10. Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report.
Matli VVK; Fariduddin MM; Asafo-Agyei KO; Bansal N
Clin Case Rep; 2021 Dec; 9(12):e05144. PubMed ID: 34917366
[TBL] [Abstract][Full Text] [Related]
11. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old.
Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A
Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482
[TBL] [Abstract][Full Text] [Related]
12. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
Chauhan S; Manov A; Dhillon GS; Shah P
Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
[TBL] [Abstract][Full Text] [Related]
13. Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review.
Kapila V; Topf J
Cureus; 2021 Aug; 13(8):e17093. PubMed ID: 34527480
[TBL] [Abstract][Full Text] [Related]
14. Euglycemic Diabetic Ketoacidosis: A Review.
Modi A; Agrawal A; Morgan F
Curr Diabetes Rev; 2017; 13(3):315-321. PubMed ID: 27097605
[TBL] [Abstract][Full Text] [Related]
15. Euglycemic diabetic ketoacidosis induced by sodium-glucose cotransporter 2 inhibitor in the setting of prolonged fasting: a case report.
Alkatheeri A; Alseddeeqi E
J Med Case Rep; 2022 Mar; 16(1):138. PubMed ID: 35346357
[TBL] [Abstract][Full Text] [Related]
16. "Normal but Catastrophic" Euglycemic Diabetic Ketoacidosis Precipitated by Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report.
Sarno MJF; Hernandez DPF; Matulac MO
Cureus; 2023 Nov; 15(11):e49236. PubMed ID: 38143642
[TBL] [Abstract][Full Text] [Related]
17. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
[TBL] [Abstract][Full Text] [Related]
18. Post-Operative Euglycemic Diabetic Ketoacidosis in a Patient With SGLT-2 Inhibitor Use and Recent Sleeve Gastrectomy.
Smith A; Holtrop J; Sadoun M
Cureus; 2021 Apr; 13(4):e14297. PubMed ID: 33968511
[TBL] [Abstract][Full Text] [Related]
19. Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy.
Baytuğan NZ; Çelik Aİ; Bezgin T; Çağdaş M
Am J Emerg Med; 2023 Sep; 71():250.e1-250.e3. PubMed ID: 37451968
[TBL] [Abstract][Full Text] [Related]
20. Euglycemic Diabetic Ketoacidosis in a 27 year-old female patient with type-1-Diabetes treated with sodium-glucose cotransporter-2 (SGLT2) inhibitor Canagliflozin.
Bader N; Mirza L
Pak J Med Sci; 2016; 32(3):786-8. PubMed ID: 27375734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]